Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire

Blood

Volumn 95, Issue 12, 2000, Pages 3990-3995

  Verfuerth, Stephanie ^b   Peggs, Karl ^b   Vyas, Paulomi ^b   Barnett, Lorna ^b   O'Reilly, Richard J ^b   Mackinnon, Stephen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LYMPHOCYTE DEPLETION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034660142     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.12.3990     Document Type: Article

References (27)

1. Goldman JM, Apperley JF, Jones L, et al. Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med. 1986;314:202-207.
2. + T-lymphocyte regeneration after intensive chemotherapy [see comments]. N Engl J Med. 1995;332:143-149.
3. Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection [see comments]. Nature, 1998;396:690-695.
4. Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood. 1987; 69:369-380.
5. Atkinson K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant. 1990;5:209-226.
6. Noel DR, Witherspoon RP, Storb R, et al. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? an observation on 56 long-term survivors. Blood. 1978;51:1087-1105.
7. Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Ann Intern Med. 1988;108:806-814.
8. Apperley JF, Mauro FR, Goldman JM, et al. Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect [published erratum appears in Br J Haematol. 1988;70:261]. Br J Haematol. 1988;69:239-245.
9. Kolb HJ, Mittermuller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990;76:2462-2465.
10. Mackinnon S, Papadopoulos EB, Carabasi MH, et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood. 1995;86:1261-1268.
11. Cochet M, Pannetier C, Regnault A, Darche S, Leclerc C, Kourilsky P. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur J Immunol. 1992;22:2639-2647.
12. Gorski J, Yassai M, Zhu X, et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping: correlation with immune status. J Immunol. 1994;152:5109-5119.
13. Siu G, Kronenberg M, Strauss E, Haars R, Mak TW, Hood L. The structure, rearrangement and expression of D beta gene segments of the murine T-cell antigen receptor. Nature. 1984;311: 344-350.
14. + circulating alpha/beta T-cell repertoires are equally complex and are characterized by different levels of steady-state TCR expression. Hum Immunol. 1996;48:52-62.
15. Dietrich PY, Caignard A, Lim A, et al. In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood. 1994;84:2815-2820.
16. Akatsuka Y, Cerveny C, Hansen JA. T cell receptor clonal diversity following allogeneic marrow grafting. Hum Immunol. 1996;48:125-134.
17. Roux E, Helg C, Chapuis B, Jeannet M, Roosnek E. T-cell repertoire complexity after allogeneic bone marrow transplantation. Hum Immunol. 1996;48:135-138.
18. Roux E, Helg C, Dumont-Girard F, Chapuis B, Jeannet M, Roosnek E. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood. 1996;87:3984-3992.
19. Claret EJ, Alyea EP, Orsini E, et al. Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. J Clin Invest. 1997;100:855-866.
20. Kernan NA, Bordignon C, Keever CA, et al. Graft failures after T cell depleted marrow transplants for leukemia: clinical and in vitro characteristics. Transplant Proc. 1987;19:29-32.
21. Maslanka K, Piatek T, Gorski J, Yassai M. Molecular analysis of T cell repertoires: spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum Immunol. 1995;44:28-34.
22. Garderet L, Dulphy N, Douay C, et al. The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood. 1998;91:340-346.
23. + subset in normal human subjects. J Immunol. 1993;151:5762-5769.
24. + population. Immunology. 1998;94:529-535.
25. Lue C, Mitani Y, Crew MD, George JF, Fink LM, Schichman SA. An automated method for the analysis of T-cell receptor repertoires: rapid RT-PCR fragment length analysis of the T-cell receptor beta chain complementarity-determining region 3. Am J Clin Pathol. 1999;111:683-690.
26. Butturini A, Seeger RC, Gale RP. Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation. Blood. 1986;68:954-956.
27. Wotton D, Ways DK, Parker PJ, Owen MJ. Activity of both Raf and Ras is necessary for activation of transcription of the human T cell receptor beta gene by protein kinase C, Ras plays multiple roles. J Biol Chem. 1993;268:17975-17982.